UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Dorie Chevlen Dorie Chevlen is a writer covering home design. Her subjects ...

Cassidy was an updates editor whose main responsibility is to write and edit articles on a range of home improvement topics. Her passion for lifestyle writing began with her editorial apprenticeship ...

Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043] None selected Not selected 21 June 2024 IgPro20 for treating dermatomyositis [TSID12014] None selected ...